Chicago, August 1, 2024 – Bioer Technology, a leading innovator in the molecular diagnostics industry, showcased its latest advancements at the ADLM 2024 (formerly AACC Annual Scientific Meeting & Clinical Lab Expo) held from July 28 to August 1 in Chicago. The event attracted professionals and experts from the clinical laboratory and diagnostics sectors, providing a platform for Bioer Technology to demonstrate its cutting-edge solutions.
At the exhibition, Bioer Technology presented four flagship products: the AutoGene 9600 Automatic PCR Analysis System, Droplet Chip Digital PCR Analysis System, QuantGene 9600 Fluorescent Quantitative Detection System, and GenePure Pro Nucleic Acid Purification System. These products highlight Bioer Technology's commitment to advancing molecular diagnostics and meeting the needs of modern clinical laboratories.
AutoGene 9600 Automatic PCR Analysis System: This fully automated system streamlines the PCR process, offering unparalleled efficiency and accuracy. The AutoGene 9600 is designed to handle high-throughput demands, making it ideal for large-scale diagnostic laboratories. /uploadfiles/2024/08/20240801151541635.pdf
Droplet Chip Digital PCR Analysis System: Known for its precision and sensitivity, this system utilizes droplet digital PCR technology to provide absolute quantification of target nucleic acids. It is particularly suited for applications requiring high sensitivity, such as rare mutation detection and copy number variation analysis. /uploadfiles/2024/08/20240801151742840.pdf
QuantGene 9600 Fluorescent Quantitative Detection System: Combining speed with accuracy, the QuantGene 9600 offers robust performance for quantitative PCR assays. Its advanced fluorescence detection capabilities ensure reliable results for a variety of applications, including gene expression analysis and pathogen detection. /uploadfiles/2024/08/20240801152725711.pdf
GenePure Pro Nucleic Acid Purification System: This versatile system simplifies nucleic acid extraction with its high-efficiency purification technology. The GenePure Pro is compatible with a wide range of sample types, delivering high-quality nucleic acids essential for downstream molecular analyses. /uploadfiles/2024/08/20240801153831901.pdf
In addition to their equipment, Bioer Technology has invested significantly in the development and production of diagnostic reagent kits. Their applications span respiratory, gastrointestinal, sexually transmitted diseases (STD), cervical cancer, blood disorders, and tropical infectious diseases. Moreover, the nucleic acid extraction kits compatible with the GenePure Pro Nucleic Acid Purification System cover a wide range of sample types, including plants, blood, tissues, oral and nasal swabs, cervical swabs, and environmental samples.
As Bioer Technology continues to innovate and expand its product portfolio, their presence at major industry events like ADLM 2024 reaffirms their status as a leader in molecular diagnostics. The company remains committed to developing solutions that empower laboratories to achieve greater precision and efficiency in their diagnostic processes, continually introducing new products to better serve humanity in the field of clinical testing.
